Belladonna Alkaloids — Class II drug recall D-170-2013
Terminated recall by West-ward Pharmaceutical Corp., reported 2013-03-06, distributed nationwide. Presence of Foreign Substance: Uncharacteristic blacks spots were found in tablets.
| Recall number | D-170-2013 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | West-ward Pharmaceutical Corp., Eatontown, NJ, United States |
| Recall initiated | 2013-01-07 |
| Classified | 2013-02-27 |
| Reported by FDA | 2013-03-06 |
| Terminated | 2015-01-21 |
| Distributed | Nationwide (US) |
| Quantity | 6,511 bottles |
| NDC | 00143-1140-10 |
| Lot numbers | 08/15, 69099A, 69099B |
Product
Belladonna Alkaloids (hyoscyamine sulfate, USP 0.1037 mg; atropine sulfate, USP 0.0194 mg; scopolamine HBr, USP 0.0065 mg) with Phenobarbital (USP 16.2 mg) Tablets, packaged in a) 1000-count tablets per bottle (NDC 0143-1140-10; b) 5000-count tablets per bottle (NDC 143-1140-51); Rx only, Manufactured by: West-ward Pharmaceutical Corp. Eatontown, NJ 07724
Reason for recall
Presence of Foreign Substance: Uncharacteristic blacks spots were found in tablets.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-170-2013. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.